|
2023 Conference Publication 1511 Macrophages regulate endothelial progenitors’ quiescence and self-renewal during homeostasis and cutaneous wound healing via paracrine signalingSim, S., Kaur, S., Styke, C., Millard, S., Blumenthal, A., Pettit, A. and Khosrotehrani, K. (2023). 1511 Macrophages regulate endothelial progenitors’ quiescence and self-renewal during homeostasis and cutaneous wound healing via paracrine signaling. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1528 |
|
2023 Conference Publication Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: A phase II randomised, double-blind, placebo-controlled pilot trialCox, Charlotte, Fry, Kirsty, Sivakumaran, Yogeesan, Spelman, Lynda and Khosrotehrani, Kiarash (2023). Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: A phase II randomised, double-blind, placebo-controlled pilot trial. HOBOKEN: WILEY. |
|
2023 Conference Publication Epidermal mutation accumulation in photodamaged skin is associated with skin cancer burden and can be targeted through ablative therapyWong, H., Lee, R., Chong, S., Kapadia, S., Murigneux, V., Freeman, M., Soyer, H., Roy, E. and Khosrotehrani, K. (2023). Epidermal mutation accumulation in photodamaged skin is associated with skin cancer burden and can be targeted through ablative therapy. 1st International Societies for Investigative Dermatology Meeting, Tokyo, Japan, 12 - 13 May 2023. Oxford, United Kingdom: Elsevier. |
|
2023 Conference Publication Trends of skin cancer numbers in solid organ transplant recipients: The TOSCANI cohort studyLee, Ruby, Tseng, Anne, Liyanage, Upekha, Brown, Susan and Khosrotehrani, Kiarash (2023). Trends of skin cancer numbers in solid organ transplant recipients: The TOSCANI cohort study. HOBOKEN: WILEY. |
|
2023 Conference Publication 275 Spatial transcriptomics of early invasive melanomas reveals molecular determinants of patient survivalZhou, C., Tan, S. X., Kao, Y., Claeson, M., Brown, S., Lambie, D., Whiteman, D., Soyer, H., Stark, M., Nguyen, Q. and Khosrotehrani, K. (2023). 275 Spatial transcriptomics of early invasive melanomas reveals molecular determinants of patient survival. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.279 |
|
2023 Conference Publication Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipientsCox, Charlotte, Lee, Ruby, Liyanage, Upekha, Brown, Susan, Isbel, Nicole, Chambers, Daniel, Griffin, Anthony, Campbell, Scott, Hopkins, Peter, Schaider, Helmut, Soyer, Peter and Khosrotehrani, Kiarash (2023). Anatomical distribution of severe keratinocyte carcinomas in solid organ transplant recipients. HOBOKEN: WILEY. |
|
2023 Conference Publication Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: a phase II randomized, double-blind, placebo-controlled pilot trialCox, C., Fry, K., Sivakumaran, Y., Spelman, L. and Khosrotehrani, K. (2023). Anti-IL17A, Ixekizumab, for treatment-resistant chronic venous leg ulcers: a phase II randomized, double-blind, placebo-controlled pilot trial. 1st International Societies for Investigative Dermatology Meeting Abstract Supplement, Tokyo, Japan, 10 - 13 May 2023. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2023.03.1530 |
|
2023 Conference Publication A pilot study using total body photography to monitor the change in size and colour of naevi during pregnancyMahon, Clare and Khosrotehrani, Kiarash (2023). A pilot study using total body photography to monitor the change in size and colour of naevi during pregnancy. HOBOKEN: WILEY. |
|
2023 Journal Article Anti‐IL17A , Ixekizumab, for treatment‐resistant chronic venous leg ulcers: a phase II randomized, double‐blind, placebo‐controlled pilot trialCox, C., Fry, K., Sivakumaran, Y., Spelman, L. and Khosrotehrani, K. (2023). Anti‐IL17A , Ixekizumab, for treatment‐resistant chronic venous leg ulcers: a phase II randomized, double‐blind, placebo‐controlled pilot trial. Journal of the European Academy of Dermatology and Venereology, 143 (5), S259-e975. doi: 10.1111/jdv.19041 |
|
2023 Journal Article Targeting Staphylococcus aureus dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: Outlook for future therapies?Bromfield, Jacoba Isobella, Hugenholtz, Philip, Frazer, Ian Hector, Khosrotehrani, Kiarash and Chandra, Janin (2023). Targeting Staphylococcus aureus dominated skin dysbiosis in actinic keratosis to prevent the onset of cutaneous squamous cell carcinoma: Outlook for future therapies?. Frontiers in Oncology, 13 1091379, 1091379. doi: 10.3389/fonc.2023.1091379 |
|
2023 Journal Article Conditional survival in patients with stage IB‐IIIA melanoma undergoing sentinel node biopsy in Queensland: a longitudinal studyTedman, Alexander James, Liyanage, Upekha E., Chong, Sharene, Rowe, Casey, von Schuckmann, Lena A., Malt, Maryrose, Green, Adele C., Smithers, B. Mark and Khosrotehrani, Kiarash (2023). Conditional survival in patients with stage IB‐IIIA melanoma undergoing sentinel node biopsy in Queensland: a longitudinal study. Australasian Journal of Dermatology, 64 (1), e34-e40. doi: 10.1111/ajd.13974 |
|
2023 Journal Article Tribute to reviewersKhosrotehrani, Kiarash and Schaider, Helmut (2023). Tribute to reviewers. Australasian Journal of Dermatology, 64 (1), 162-166. doi: 10.1111/ajd.13990 |
|
2023 Journal Article Risk factors associated with first and second primary melanomas in a high-incidence populationOlsen, Catherine M., Pandeya, Nirmala, Dusingize, Jean Claude, Neale, Rachel E., MacGregor, Stuart, Law, Matthew H., Whiteman, David C., for the QSkin Study, Hayward, Nicholas K., Khosrotehrani, Kiarash and Gordon, Louisa G. (2023). Risk factors associated with first and second primary melanomas in a high-incidence population. JAMA Dermatology, 159 (1), 37-46. doi: 10.1001/jamadermatol.2022.4975 |
|
2022 Conference Publication Epidermal ablation reduces keratinocyte cancer burden by lowering skin mutation loadWong, H., Lee, R., Roy, E., Kapadia, S., Murigneux, V., Chong, S., Freeman, M. and Khosrotehrani, K. (2022). Epidermal ablation reduces keratinocyte cancer burden by lowering skin mutation load. 51st Annual ESDR Meeting, Amsterdam, Netherlands, 28 September-1 October 2022. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2022.09.449 |
|
2022 Conference Publication Variation in epidermal mutation burden after field treatment with topical 5-fluorouracilLee, R., Wong, H., Brown, S., Roy, E. and Khosrotehrani, K. (2022). Variation in epidermal mutation burden after field treatment with topical 5-fluorouracil. 51st Annual ESDR Meeting, Amsterdam, Netherlands, 28 September-1 October 2022. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2022.09.504 |
|
2022 Journal Article Macrophages in skin wounds: functions and therapeutic potentialSim, Seen Ling, Kumari, Snehlata, Kaur, Simranpreet and Khosrotehrani, Kiarash (2022). Macrophages in skin wounds: functions and therapeutic potential. Biomolecules, 12 (11) 1659, 1-31. doi: 10.3390/biom12111659 |
|
2022 Journal Article Melanoma tumour vascularization and tissue-resident endothelial progenitor cellsHashemi, Ghazaleh, Dight, James, Khosrotehrani, Kiarash and Sormani, Laura (2022). Melanoma tumour vascularization and tissue-resident endothelial progenitor cells. Cancers, 14 (17) 4216, 1-23. doi: 10.3390/cancers14174216 |
|
2022 Journal Article Skin biomechanics: a potential therapeutic intervention target to reduce scarringHosseini, Motaharesadat, Brown, Jason, Khosrotehrani, Kiarash, Bayat, Ardeshir and Shafiee, Abbas (2022). Skin biomechanics: a potential therapeutic intervention target to reduce scarring. Burns and Trauma, 10 tkac036, tkac036. doi: 10.1093/burnst/tkac036 |
|
2022 Journal Article Myeloid Wls expression is dispensable for skin wound healing and blood vessel regenerationSim, Seen Ling, Blumenthal, Antje, Kaur, Simranpreet and Khosrotehrani, Kiarash (2022). Myeloid Wls expression is dispensable for skin wound healing and blood vessel regeneration. Frontiers in Endocrinology, 13 957833, 957833. doi: 10.3389/fendo.2022.957833 |
|
2022 Journal Article Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithmsAung, Thazin Nwe, Shafi, Saba, Wilmott, James S., Nourmohammadi, Saeed, Vathiotis, Ioannis, Gavrielatou, Niki, Fernandez, Aileen, Yaghoobi, Vesal, Sinnberg, Tobias, Amaral, Teresa, Ikenberg, Kristian, Khosrotehrani, Kiarash, Osman, Iman, Acs, Balazs, Bai, Yalai, Martinez-Morilla, Sandra, Moutafi, Myrto, Thompson, John F., Scolyer, Richard A. and Rimm, David L. (2022). Objective assessment of tumor infiltrating lymphocytes as a prognostic marker in melanoma using machine learning algorithms. eBioMedicine, 82 104143, 1-14. doi: 10.1016/j.ebiom.2022.104143 |
